Newstral
Article
jdsupra.com on 2017-11-09 03:25
Digital Health: FDA Announces New Policy for Genetic Testing Regulation
Related news
- Genetic Testing, Genome Sequencing, and the FDAjdsupra.com
- 23andMe reboots genetic health testing, now with FDA approvalArs Technica
- FDA Authorizes 23andMe to Market Genetic Testing For Bloom SyndromeTechCrunch
- 23andMe Is Back in the Genetic Testing Business With FDA Approvalgizmodo.com
- 23andMe gets FDA approval to use its genetic testing service — for one disease onlybizjournals.com
- Sure Genomics wants to sell private genetic profiles for $2,500, but it’s really testing the FDAThe Verge
- FDA Regulation of COVID-19 Apps, Digital Therapeutics, and Other Digital Health Technologiesjdsupra.com
- Genetic Testing – Unintended Consequences?jdsupra.com
- Clarifying Digital Health and Software Regulation: FDA Releases Three New Guidance Documentsjdsupra.com
- New CMS National Coverage Determination and FDA Regulatory Approach: the Next Generation for NGS Testing Policy?jdsupra.com
- SThe ethics of genetic testingstudentnewspaper.org
- Genetic testing allows precision prescribingdailypress.com
- FDA balks at CBD regulationArkansas Online
- FDA issues digital health policy guidance for multiple function device productsjdsupra.com
- FDA Signals Easier Rule on Genetic Testswsj.com
- First FDA-approved genetic therapy fights leukemiaengadget
- FDA relents on home genetic teststriblive.com
- Genetic-test service back with FDA OKnwaonline.com